期刊文献+

阿利克仑的合成 被引量:2

Synthesis of aliskiren
下载PDF
导出
摘要 对肾素抑制剂阿利克仑的合成工艺进行研究。采用化学拆分法分别制备了合成阿利克仑的手性片段化合物1和2,再经5步汇聚式合成得到目标产物阿利克仑,总收率15.6%。中间体和目标产物经熔点、NMR、ESI-MS表征。所采用的工艺路线光学纯度可控,收率较好,操作简便,无需特殊试剂和复杂的分离纯化过程,具备一定的工业化生产潜力。 This paper describes a practical process for the preparation of aliskiren. Chiral building blocks 1 and 2 were prepared by chemical resolution, and a following five-step convergent synthesis led to aliskiren with an over- all yield of 15.6%. The intermediates and the target compound were characterized by melting points, NMR and MS. The convergent synthetic process of aliskiren highlights reasonable yields, ease of operation, high stereoselectivity as well as only one chromatographic purification, and thus should be amenable to large-scale production.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2011年第5期400-406,共7页 Journal of China Pharmaceutical University
关键词 阿利克仑 肾素抑制剂 合成工艺 抗高血压药物 aliskiren renin inhibitor synthetic process antihypertensive agents
  • 相关文献

参考文献13

  • 1Jensen C, Herold P, Brunner HR. Aliskiren : the first renin inhibitor for clinical treatment [ J ]. Nat Rev Drug Discov,2008,7 (5) : 399 -410.
  • 2Staessen JA,Li Y,Richart T. Oral renin inhibitors[ J]. Lancet , 2006,368(9 545):1 449 -1 456.
  • 3Schmieder RE, Philipp T,Guerediaga J, et al. Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren : a 12-month randomized, double-blind comparator trial with hydrochlorothiazide [ J ]. Circulation, 2009,119 ( 3 ) : 417 - 425.
  • 4Aliskiren/hydrochlomthiazide ( Tektuma HCT) for hypertension [J]. Med Lett Drugs Ther,2008,50(1 293) :65 -66.
  • 5Aliskiren/vatsartan (Valtuma) for hypertension [ J ]. Med Lett Drugs Ther ,2009 ,51 (1 326) :94 -95.
  • 6Aliskiren/amlodipine (Tekamlo) : another combination tablet for hypertension[ J ]. Med Lett Drugs Ther, 2010,52 ( 1 352 ) : 94 - 95.
  • 7Goschke RG, Maibaum UJK, Schilling W, et al. δ-amino-γ- hydroxy-ω-aryl-alkanoic acid amides : US, 5559111 [ P ]. 1996- 09 -24.
  • 8Dong H ,Zhang ZL, Huang JH, Ma RJ, et al. Practical synthesis of an orally active renin inhibitor aliskiren [ J ]. Tetrahedron Lett, 2005,46(37) :6 337 -6 340.
  • 9Herold P, Stutz S, Indolese A. Production of N-substituted 2,7- dialkyl-4-hydroxy- 5-amino-8-arly-octanoylamides : US, 7009078 [ P]. 2006-03-07.
  • 10Goeschke R, Stutz S, Heinzelmann W, et al. The nonchiral bislactim diethoxy ether as a highly stereo-inducing synthon for sterically hindered, γ-branched α-amino acids : a practical, large- scale route to an intermediate of the novel renin inhibitor aliskiren[ J ]. Chimica Acta ,2003 ,-( 8 ) :2 848 - 2 870.

同被引文献8

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部